T 0205/14 (Ibandronate sodium, Form QQ/TEVA) of 18.6.2015

European Case Law Identifier: ECLI:EP:BA:2015:T020514.20150618
Date of decision: 18 June 2015
Case number: T 0205/14
Application number: 05791142.2
IPC class: A61K 31/663
A61P 19/10
C07F 9/38
Language of proceedings: EN
Distribution: D
Download and more information:
Decision text in EN (PDF, 939.929K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: CRYSTALLINE FORM OF IBANDRONATE SODIUM AND PROCESSES FOR PREPARATION THEREOF
Applicant name: Teva Pharmaceutical Industries Ltd
Opponent name: Hexal AG
Actavis Group PTC EHF
Pharmathen Industrial S.A.
Board: 3.3.01
Headnote: -
Relevant legal provisions:
European Patent Convention Art 54
European Patent Convention Art 56
Keywords: Right of priority - assignment
Main request: novelty (yes), inventive step (no)
Requests AR1-AR5, MRa, AR1a-AR5a: inventive step (no)
Request AR6: admitted (no)
Catchwords:

-

Cited decisions:
G 0001/92
G 0003/92
G 0003/99
G 0001/13
J 0019/87
J 0012/00
J 0002/01
J 0004/10
R 0016/09
T 0595/90
T 1008/96
T 0005/05
T 0062/05
T 0788/05
T 0493/06
T 0382/07
T 1933/12
T 0160/13
Citing decisions:
T 0577/11
T 2466/13
T 0517/14
T 0969/14
T 1201/14
T 1103/15

25 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: II Conditions to be met by an Application

Case Law Book: III Amendments

Case Law of the Enlarged Board

General Case Law